Olympiad Research’s Compugen CGEN Stock Holding History

Olympiad Research’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-32,009	Closed	-$138K	–	347
2021 Q4	$138K	Buy	+32,009	New	+$173K	0.05%	239

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Olympiad Research's CGEN Position: Q1 2022 in Review

Olympiad Research sold out of Compugen (CGEN) in Q1 2022, closing a stake of 32,009 shares — an estimated $138K sold.

Olympiad Research first reported a position in CGEN in Q4 2021 and held it in 1 quarter. The position peaked at $138K in Q4 2021. 110 funds tracked by Wall St. Rank hold CGEN as of Q1 2022.

Olympiad Research reported no remaining Compugen position as of Q1 2022 after selling out during the quarter.
Olympiad Research sold 32,009 Compugen shares in Q1 2022, an estimated $138K.
Olympiad Research first reported a position in Compugen in Q4 2021 and held it in 1 quarter.
Olympiad Research's Compugen position peaked at $138K in Q4 2021.
110 funds tracked by Wall St. Rank held Compugen as of Q1 2022.

Based on Olympiad Research's 13F filing for Q1 2022, filed 10 May 2022.